Immunology Expertise Svar Life Science specializes in immunological areas such as complement system activation and immunogenicity, with capabilities in cell engineering, assay development, and contract research. This suggests opportunities to upsell custom assays, immunogenicity testing packages, and bespoke cell-based platforms for pharma and biotech customers.

Platform Expansion Recent launches include the Anti-CCP2 assay for rheumatoid arthritis and the iLite cell-based reporter gene platform, plus the AAV Immunogenicity Assay Platform. These product expansions indicate cross-sell potential to existing customers needing broader assay suites and platform-based services.

Biologics Support With GMP Potency testing expanded to a wider pharma audience and capabilities in lot release and in-process controls, there is a clear sales path to biologics manufacturers seeking compliance-ready potency and stability testing across development stages.

Strategic Partnerships Past collaborations with Akero Therapeutics and Gyros Protein Technologies demonstrate Svar’s openness to co-developed solutions. This can be leveraged to pursue co-marketing, joint development, or integration partnerships to reach new segments and accelerate adoption.

Accessibility and Engagement Introduction of a free consultancy service signals a customer-friendly approach and a low-friction entry point. This can be capitalized by capturing early discussions for needs assessment, then routing to paid assay development or contract research engagements.